Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to IGC. [ FAQ on what and how to ask] For non-IGC questions, click the logo in the upper-right corner to return to the main page and ask there.
Unlock YouTube Video by Subscribing to iPick.ai Premium!
Not available
Address: 10224 Falls Road, Potomac, MD, United States, 20854
Employees: 70
IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer's disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.
Founder, President, CEO & Director
VP, Principal Financial Officer, Chief Compliance Officer & Non-Independent Director
Director of Operations
Director of Accounting & Senior Director
My Watchlist
